Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Statin Study (REGRESS): J.W. Jukema, A.V.G. Bruschke, A.J. Van Boven, J.H.C. Reiber, E.T. Bal, A.H. Zwinderman, H. Jansen, G.J.M. Boerma, F.M. Van Rappard, K.I. Lie. Department of Cardiology, University Hospital Leiden, Leiden, The Netherlands. Circulation 1995;91: 2528–40